Xénia Latypova

ORCID: 0000-0003-0809-3734
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Genetics and Neurodevelopmental Disorders
  • Neurogenetic and Muscular Disorders Research
  • Genomics and Rare Diseases
  • Ubiquitin and proteasome pathways
  • RNA modifications and cancer
  • Cellular transport and secretion
  • Alzheimer's disease research and treatments
  • RNA Research and Splicing
  • Congenital heart defects research
  • Genomic variations and chromosomal abnormalities
  • RNA regulation and disease
  • Cardiomyopathy and Myosin Studies
  • Genetic factors in colorectal cancer
  • Signaling Pathways in Disease
  • Cardiac electrophysiology and arrhythmias
  • Myasthenia Gravis and Thymoma
  • Muscle Physiology and Disorders
  • Microtubule and mitosis dynamics
  • Ion channel regulation and function
  • Pluripotent Stem Cells Research
  • Genetic Syndromes and Imprinting
  • Mitochondrial Function and Pathology
  • Hereditary Neurological Disorders
  • Neuroscience and Neuropharmacology Research
  • Ocular Disorders and Treatments

Assistance Publique – Hôpitaux de Paris
2020-2024

Génétique Médicale & Génomique Fonctionelle
2016-2024

Hôpital Robert-Debré
2024

Institut du Thorax
2015-2022

Inserm
2015-2022

Grenoble Institute of Neurosciences
2020-2022

Centre Hospitalier Universitaire de Nantes
2016-2022

Centre Hospitalier Universitaire de Grenoble
2020-2022

Université Grenoble Alpes
2020-2022

Centre National de la Recherche Scientifique
2015-2021

Sébastien Küry Geeske M. van Woerden Thomas Besnard Martina Proietti Onori Xénia Latypova and 95 more Meghan C. Towne Megan T. Cho Trine Prescott Melissa A. Ploeg Stephan Sanders Holly A.F. Stessman Aurora Pujol Ben Distel Laurie Robak Jonathan A. Bernstein Anne‐Sophie Denommé‐Pichon Gaëtan Lesca Elizabeth A. Sellars Jonathan Berg Wilfrid Carré Øyvind L. Busk Bregje W.M. van Bon Jeff L. Waugh Matthew A. Deardorff George Hoganson Katherine B. Bosanko Diana Johnson Tabib Dabir Øystein L. Holla Ajoy Sarkar Kristian Tveten Julitta de Bellescize Geir J. Braathen Paulien A. Terhal Dorothy K. Grange Arie van Haeringen Christina Lam Ghayda Mirzaa Jennifer Burton Elizabeth Bhoj Jessica Douglas Avni Santani Addie I. Nesbitt Katherine L. Helbig Marisa V. Andrews Amber Begtrup Sha Tang Koen L.I. van Gassen Jane Juusola Kimberly Foss Gregory M. Enns Ute Moog Katrin Hinderhofer Nagarajan Paramasivam Sharyn A. Lincoln Brandon H. Kusako Pierre Lindenbaum Éric Charpentier C. Nowak Elouan Chérot Thomas Simonet Claudia Ruivenkamp Sihoun Hahn Donna M. Brown Fan Xia Sébastien Schmitt Wallid Deb Dominique Bonneau Mathilde Nizon Delphine Quinquis Jamel Chelly Gabrielle Rudolf Damien Sanlaville Philippe Parent Brigitte Gilbert‐Dussardier Annick Toutain V. Reid Sutton Jenny Thies Lisenka E.L.M. Peart-Vissers Pierre Boisseau Marie Vincent Andreas M. Grabrucker Christèle Dubourg Wen‐Hann Tan Nienke E. Verbeek Martin Granzow Gijs W.E. Santen Jay Shendure Bertrand Isidor Laurent Pasquier Richard Redon Yaping Yang Matthew W. State Tjitske Kleefstra Benjamin Cogné Slavé Petrovski Kyle Retterer Evan E. Eichler Jill A. Rosenfeld Pankaj B. Agrawal

10.1016/j.ajhg.2017.10.003 article EN publisher-specific-oa The American Journal of Human Genetics 2017-11-01

Background Human genetically inherited cardiac diseases have been studied mainly in heterologous systems or animal models, independent of patients' genetic backgrounds. Because sources human cardiomyocytes ( CM s) are extremely limited, the use urine samples to generate induced pluripotent stem cell–derived s would be a noninvasive method identify dysfunctions that lead pathologies within specific The objective was validate CMs differentiated from urine‐derived (UhiPS) cells as new cellular...

10.1161/jaha.115.002159 article EN cc-by-nc-nd Journal of the American Heart Association 2015-09-16
Benjamin Cogné Sophie Ehresmann Éliane Beauregard‐Lacroix Justine Rousseau Thomas Besnard and 95 more Thomas X. Garcia Slavé Petrovski Shiri Avni Kirsty McWalter Patrick R. Blackburn Stephan Sanders Kévin Uguen Jacqueline Harris Julie S. Cohen Moira Blyth Anna Lehman Jonathan Berg Mindy Li Usha Kini Shelagh Joss Charlotte von der Lippe Christopher T. Gordon Jennifer Humberson Laurie Robak Daryl A. Scott V. Reid Sutton Cara Skraban Jennifer J. Johnston Annapurna Poduri Magnus Nordenskjöld Vandana Shashi Erica H. Gerkes Ernie M.H.F. Bongers Christian Gilissen Yuri A. Zárate Malin Kvarnung Kevin P. Lally Peggy Kulch Brina Daniels Andrés Hernández Nicholas Stong Julie McGaughran Kyle Retterer Kristian Tveten Jennifer A. Sullivan Madeleine R. Geisheker Asbjørg Stray‐Pedersen Jennifer Tarpinian Eric W. Klee Julie C. Sapp Jacob Zyskind Øystein L. Holla Emma Bedoukian Francesca Filippini Anne Guimier A. Picard Øyvind L. Busk Jaya Punetha Rolph Pfundt Anna Lindstrand Ann Nordgren Fayth M. Kalb Megha Desai Ashley H. Ebanks Shalini N. Jhangiani Tammie Dewan Zeynep Coban‐Akdemir Aida Telegrafi Elaine H. Zackai Amber Begtrup Xiaofei Song Annick Toutain Ingrid M. Wentzensen Sylvie Odent Dominique Bonneau Xénia Latypova Wallid Deb Sylvia Redon Frédéric Bilan Marine Legendre Caitlin Troyer Kerri Whitlock Oana Caluseriu Marine I. Murphree Pavel N. Pichurin Katherine Agre Ralitza H. Gavrilova Tuula Rinne Meredith Park Catherine Shain Erin L. Heinzen Rui Xiao Jeanne Amiel Stanislas Lyonnet Bertrand Isidor Leslie G. Biesecker Dan Lowenstein Jennifer E. Posey Anne‐Sophie Denommé‐Pichon Claude Férec

10.1016/j.ajhg.2019.01.010 article EN publisher-specific-oa The American Journal of Human Genetics 2019-03-01

10.1016/j.ajhg.2020.04.005 article EN publisher-specific-oa The American Journal of Human Genetics 2020-05-07

Abstract Embryonic development is dictated by tight regulation of DNA replication, cell division and differentiation. Mutations in repair replication genes disrupt this equilibrium, giving rise to neurodevelopmental disease characterized microcephaly, short stature chromosomal breakage. Here, we identify biallelic variants two components the RAD18-SLF1/2-SMC5/6 genome stability pathway, SLF2 SMC5 , 11 patients with stature, cardiac abnormalities anemia. Patient-derived cells exhibit a unique...

10.1038/s41467-022-34349-8 article EN cc-by Nature Communications 2022-11-04

A rare syndromic form of intellectual disability with impaired speech was recently found associated mutations in CHAMP1 (chromosome alignment-maintaining phosphoprotein 1), the protein product which is directly involved microtubule-kinetochore attachment. Through whole-exome sequencing six unrelated nonconsanguineous families having a sporadic case disability, we identified novel de novo truncating CHAMP1: c.1880C>G p.(Ser627*), c.1489C>T; p.(Arg497*), c.1876_1877delAG; p.(Ser626Leufs*4),...

10.1002/humu.22952 article EN Human Mutation 2016-01-11

<title>Abstract</title> SAP102, a member of the membrane-associated guanylate kinase proteins family, is scaffolding protein encoded by <italic>DLG3</italic> gene whose hemizygous variants with loss-of-function effect are associated X-linked Intellectual developmental disorder 90. We gathered international data from 17 new individuals 16 different (10 pathogenic and 6 uncertain significance), reviewed genotypic phenotypic 37 previously published families 34 variants. Using family...

10.21203/rs.3.rs-5998122/v1 preprint EN cc-by Research Square (Research Square) 2025-03-10

Germline variants that disrupt components of the epigenetic machinery cause syndromic neurodevelopmental disorders. Using exome and genome sequencing, we identified de novo in KDM2A , a lysine demethylase crucial for embryonic development, 18 individuals with developmental delays and/or intellectual disabilities. The severity ranged from learning disabilities to severe disability. Other core symptoms included feeding difficulties, growth issues such as intrauterine restriction, short stature...

10.1101/2025.03.31.25324695 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2025-04-02

Abstract Background Genomics enables individualized diagnosis and treatment, but large challenges remain to functionally interpret rare variants. To date, only one causative variant has been described for KCNK9 imprinting syndrome (KIS). The genotypic phenotypic spectrum of KIS yet be the precise mechanism disease fully understood. Methods This study discovers mechanisms underlying (KIS) by describing 15 novel alterations from 47 KIS-affected individuals. We use clinical genetics...

10.1186/s13073-022-01064-4 article EN cc-by Genome Medicine 2022-06-13

ABSTRACT Individuals with monoallelic pathogenic variants in the histone lysine methyltransferase DOT1L display global developmental delay and varying congenital anomalies. However, impact of loss remains unclear. Here, we present a largely female cohort 11 individuals delays dysmorphic facial features. We found that include missense clustered catalytic domain, frameshift, stop-gain variants. demonstrate specific cause activity therefore sought to define effects decreased function. Using...

10.1101/2024.10.31.24314716 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2024-11-02
Coming Soon ...